We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
First Bank
FRBA
$454M
| $330K | ﹤0.01% |
22,755
-25
| -0.1% | -$371 |
|
|
BDSI
2677
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $329K | ﹤0.01% |
106,061
-2,287
| -2% | -$7.7K |
|
2678
Distribution Solutions Group
DSGR
$1.61B
| $328K | ﹤0.01% |
11,982
-362
| -3% | -$9.2K |
|
2679
BioXcel Therapeutics
BTAI
$27.8M
| $327K | ﹤0.01% |
1,006
+49
| +5% | +$21K |
|
2680
Five Star Bancorp
FSBC
$1.13B
| $326K | ﹤0.01% |
+10,883
| New | +$305K |
|
|
AHT
2681
Ashford Hospitality Trust
AHT
$21M
| $324K | ﹤0.01% |
3,377
+2,060
| +156% | +$257K |
|
|
GNOG
2682
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $322K | ﹤0.01% |
32,328
-671
| -2% | -$9.5K |
|
|
ONIT
2683
Onity Group
ONIT
$332M
| $321K | ﹤0.01% |
8,025
-17
| -0.2% | -$574 |
|
2684
908 Devices
MASS
$364M
| $319K | ﹤0.01% |
12,345
+3,567
| +41% | +$105K |
|
|
AMTI
2685
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $319K | ﹤0.01% |
22,818
-433
| -2% | -$8.54K |
|
2686
Superior Group of Companies
SGC
$225M
| $318K | ﹤0.01% |
14,511
-454
| -3% | -$10.8K |
|
2687
Amalgamated Financial
AMAL
$1.49B
| $313K | ﹤0.01% |
18,649
-29
| -0.2% | -$505 |
|
2688
Greenlight Captial
GLRE
$506M
| $313K | ﹤0.01% |
39,906
-1,236
| -3% | -$9.07K |
|
|
GBIO
2689
DELISTED
Generation Bio
GBIO
| $311K | ﹤0.01% |
4,388
-123
| -3% | -$21.5K |
|
2690
Safe Bulkers
SB
$774M
| $311K | ﹤0.01% |
82,619
+1,371
| +2% | +$5.59K |
|
2691
Blue Bird Corp
BLBD
$2.18B
| $308K | ﹤0.01% |
19,675
-431
| -2% | -$8.55K |
|
2692
Erasca
ERAS
$6.39B
| $308K | ﹤0.01% |
19,742
+2,100
| +12% | +$36K |
|
2693
Limoneira
LMNR
$251M
| $308K | ﹤0.01% |
20,543
-285
| -1% | -$4.47K |
|
2694
Spero Therapeutics
SPRO
$73M
| $308K | ﹤0.01% |
19,261
-329
| -2% | -$5.22K |
|
2695
Fidelity D&D Bancorp
FDBC
$317M
| $306K | ﹤0.01% |
5,187
-213
| -4% | -$11.3K |
|
2696
VistaGen Therapeutics
VTGN
$12.8M
| $306K | ﹤0.01% |
5,234
-108
| -2% | -$7.03K |
|
|
CLVS
2697
DELISTED
Clovis Oncology, Inc.
CLVS
| $306K | ﹤0.01% |
112,877
+4,894
| +5% | +$18.1K |
|
2698
National CineMedia
NCMI
$378M
| $305K | ﹤0.01% |
10,864
-329
| -3% | -$10.5K |
|
2699
Noodles & Co
NDLS
$107M
| $302K | ﹤0.01% |
4,164
-130
| -3% | -$11.8K |
|
2700
Passage Bio
PASG
$14.1M
| $302K | ﹤0.01% |
2,379
+24
| +1% | +$3.92K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.